Loading...
•
Jun 30, 2022
Sanara MedTech Q2 2022 Earnings Report
Generated record revenue in the second quarter of 2022.
Key Takeaways
Sanara MedTech reported record revenue in Q2 2022, marking the first quarter with over $3 million in sales each month. The company also completed the acquisition of Scendia Biologics, LLC.
Generated record revenue in the second quarter of 2022.
Achieved over $3 million in sales in each month during the quarter.
Acquired Scendia Biologics, LLC.
Integrated the Scendia team and biologic products into Sanara.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...